TrialEBioMedicine2018

Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942.

Gary Burgess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.